Cargando…
Potential Role of the Fragile Histidine Triad in Cancer Evo-Dev
SIMPLE SUMMARY: Tumor development follows an evolutionary pattern of “mutation-selection-adaptation”, characterized by exogenous oncogenic induction and endogenous replicative stress. The fragile histidine triad (FHIT) is a tumor suppressor. Aberrant transcription or reduction in the transcription a...
Autores principales: | Niu, Zheyun, Jiang, Dongming, Shen, Jiaying, Liu, Wenbin, Tan, Xiaojie, Cao, Guangwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9954361/ https://www.ncbi.nlm.nih.gov/pubmed/36831487 http://dx.doi.org/10.3390/cancers15041144 |
Ejemplares similares
-
Cancer Evo–Dev: A Theory of Inflammation-Induced Oncogenesis
por: Liu, Wenbin, et al.
Publicado: (2021) -
The Clinical Relevance of Fragile Histidine Triad Protein (FHIT) in Patients with Bladder Cancer
por: Liu, Xiao-Ping, et al.
Publicado: (2018) -
The role of human papillomavirus type 16 and the fragile histidine triad gene in the outcome of cervical neoplastic lesions
por: Terry, G, et al.
Publicado: (2004) -
Molecular and epigenetic analysis of the fragile histidine triad tumour suppressor gene in equine sarcoids
por: Strazzullo, Maria, et al.
Publicado: (2012) -
In silico study of fragile histidine triad interaction domains with MDM2 and p53
por: Eslamparast, Ameneh, et al.
Publicado: (2014)